Literature DB >> 20109608

Unrelated umbilical cord blood unit selection.

Andromachi Scaradavou1.   

Abstract

The aims of this review are to summarize the relevant published literature regarding cord blood (CB) graft characteristics and their impact on transplantation outcomes, to present new analyses from patients transplanted with CB units from the New York Blood Center's National Cord Blood Program, and to propose new guidelines for prioritizing CB unit selection. (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20109608     DOI： 10.1053/j.seminhematol.2009.10.003

Source DB:  PubMed          Journal:  Semin Hematol        ISSN： 0037-1963            Impact factor:   3.851


  6 in total

1.  A prospective investigation of cell dose in single-unit umbilical cord blood transplantation for adults with high-risk hematologic malignancies.

Authors:  U Sobol; A Go; S Kliethermes; S Bufalino; T Rodriguez; S Smith; M Parthasarathy; P Stiff
Journal:  Bone Marrow Transplant       Date:  2015-09-14       Impact factor: 5.483

2.  Constituting a public umbilical cord blood bank in South Africa.

Authors:  J Mellet; M Alessandrini; H C Steel; M S Pepper
Journal:  Bone Marrow Transplant       Date:  2015-01-26       Impact factor: 5.483

3.  Effect of donor-recipient HLA matching at HLA A, B, C, and DRB1 on outcomes after umbilical-cord blood transplantation for leukaemia and myelodysplastic syndrome: a retrospective analysis.

Authors:  Mary Eapen; John P Klein; Guillermo F Sanz; Stephen Spellman; Annalisa Ruggeri; Claudio Anasetti; Maria Brown; Richard E Champlin; Joan Garcia-Lopez; Gareth Hattersely; Gesine Koegler; Mary J Laughlin; Gerard Michel; Samir K Nabhan; Franklin O Smith; Mary M Horowitz; Eliane Gluckman; Vanderson Rocha
Journal:  Lancet Oncol       Date:  2011-10-06       Impact factor: 41.316

Review 4.  How I treat: the selection and acquisition of unrelated cord blood grafts.

Authors:  Juliet N Barker; Courtney Byam; Andromachi Scaradavou
Journal:  Blood       Date:  2010-12-13       Impact factor: 22.113

5.  Phase I/II Trial of StemRegenin-1 Expanded Umbilical Cord Blood Hematopoietic Stem Cells Supports Testing as a Stand-Alone Graft.

Authors:  John E Wagner; Claudio G Brunstein; Anthony E Boitano; Todd E DeFor; David McKenna; Darin Sumstad; Bruce R Blazar; Jakub Tolar; Chap Le; Julie Jones; Michael P Cooke; Conrad C Bleul
Journal:  Cell Stem Cell       Date:  2015-12-05       Impact factor: 24.633

6.  Immobilisation of Delta-like 1 ligand for the scalable and controlled manufacture of hematopoietic progenitor cells in a stirred bioreactor.

Authors:  Rebecca L L Moore; Matthew J Worrallo; Peter D Mitchell; Jon Harriman; Katie E Glen; Robert J Thomas
Journal:  BMC Biotechnol       Date:  2017-08-04       Impact factor: 2.563
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.